Skip to main content
PARK logo

PARK · Park Dental Partners, Inc.

Track PARK — free
$18.27 -0.70 (-3.69%) At close · Nov 19
Market Cap
$101.12M
Shares
5.54M
Volume · Nov 19 43.09K Avg daily vol (3M) 37.94K

Price & Indicators

 

Key stats

Close
$18.27
Open
$18.87
Day range
$17.95–19.04
52-week closing range
$10.25–23.05
Average volume, 30 days
44K
Short interest
27K · 0.5% of shares · 1.0 days
Short volume, last session
62%
Last earnings
Nov 13, 2026
Latest filing
10-Q · Nov 12
Price history
Dec 2025 to Nov 2026

Up next

Feb 25, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 13
Earnings call
6% revenue growth; Village acquisition raises 2026 outlook

Park Dental Partners reported third-quarter revenue of $64.9 million, up 6% year over year, and raised its full-year 2026 revenue outlook to $262 to $265 million after closing Village Family Dental, adding 47 doctors across 12 practices in North Carolina.

5 source passages
Good morning, everyone, and thank you for joining Park Dental Partners' third quarter 2026 earnings call. We were pleased with third quarter revenue as the quarter was in line with our expected growth totaling $64.9 million, an increase of 6% over the prior year period. A significant milestone for our organization occurred this past week with the closing of our Village Family Dental transaction. Village brings 47 doctors across 12 practices into Park Dental Partners and expands our reach into our fourth state, North Carolina. Revenue of $262 to $265 million, compared with prior outlook of $256 to $260 million. Village Family Dental represents an important step forward in that strategy. Open the document at this passage
Nov 13
Current report 8-K/A Events of Nov 12
Revenue and EBITDA outlook midpoint growth corrected

Park Dental Partners corrected midpoint growth to 7.8% for revenue and (1.4)% for Adjusted EBITDA; the $262.0 – $265.0 revenue and $21.2 – $22.2 Adjusted EBITDA ranges were unchanged.

Financial results
4 source passages
Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its third quarter financial results for 2026. Correction: This press release corrects the “Percent Change (At Midpoint)” in the outlook table contained in the Company's press release originally issued on November 12, 2026. The corrected table is included herein. There were no changes to the outlook ranges. In all other respects, the press release remains unchanged. Revenue | | | $262.0 – $265.0 | | | $ | 244.5 | | | 7.8 | % Adjusted EBITDA | | | $21.2 – $22.2 | | | $ | 22.0 | | | (1.4) | % Open the document at this passage
Nov 12
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises as Adjusted EBITDA declines

For the nine months ended September 30, 2026, Park Dental Partners reported revenue of $193.8 million, up $10.5 million, while Adjusted EBITDA fell $1.2 million to $17.1 million; same-practice revenue grew 3.0%.

Read from the MD&A section
4 source passages
As a dental resource organization (“DRO”), Park Dental Partners, Inc. provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to our affiliated general and multi-specialty dental practices in Minnesota, Wisconsin and Arizona. Total revenues for the nine months ended September 30, 2026, increased $10.5 million, or 5.8%, to $193.8 million from $183.3 million for the nine months ended September 30, 2025. Adjusted EBITDA for the nine months ended September 30, 2026 was $17.1 million, a decrease of $1.2 million from the $18.3 million Adjusted EBITDA for the nine months ended September 30, 2025, primarily due to the $2.3 million increase in general and administrative expenses after adjustment, offset in part by the $1.1 million increase in Adjusted Gross margin. Same Practice Revenue Growth for the nine months ended September 30, 2026 was 3.0%, or 280 bps lower than the 5.8% Same Practice Revenue Growth for the nine months ended September 30, 2025. Open the document at this passage
Nov 12
Current report 8-K
Revenue rises 6.0% as adjusted EBITDA declines

Park Dental Partners reported third-quarter 2026 revenue of $64.9 million, up 6.0%, while adjusted EBITDA declined to $5.0 million from $5.3 million. Following its November 6, 2026 Village Family DSO acquisition, it projects 2026 revenue of $262.0 – $265.0 million.

Financial results
4 source passages
Revenue increased 6.0% to $64.9 million for the third quarter of 2026, compared to $61.3 million in the prior-year period. Adjusted EBITDA was $5.0 million for the third quarter of 2026, compared to $5.3 million in the prior-year period. As announced earlier this week, we completed the acquisition of Village Family DSO on November 6, 2026. Revenue | | | | $262.0 – $265.0 Open the document at this passage
Nov 9
Current report 8-K Events of Nov 6
Village Family Dental acquisition closes with $25.0 million revolver

Park Dental Partners completed its Village Family Dental acquisition on November 6, 2026, for base consideration of approximately $39.1 million. The credit agreement amendment increased the revolving credit commitment from $15.0 million to $25.0 million.

Entered into a material agreement, Completed an acquisition or sale of assets, New debt or off-balance-sheet obligation, Unregistered sale of equity, Regulation FD disclosure Read from the first part of this long document
3 source passages
On November 6, 2026, Park Dental Partners, Inc. completed its previously announced acquisition of the dental services organization supporting Village Family Dental and affiliation with the Village Family Dental professional practices. The Transaction Agreement provided for base consideration of approximately $39.1 million, including the 474,535 restricted shares of the Company’s common stock issued in connection with the rollover, which were valued at approximately $9.2 million for purposes of the Transaction Agreement. The principal changes made by the Credit Agreement Amendment are: (i) an increase in the maximum revolving credit commitment from $15.0 million to $25.0 million; (ii) the addition of the Company's North Carolina subsidiary as a co-borrower under the Credit Agreement; and (iii) the provision of certain additional collateral and security arrangements and updates to certain definitions, covenants and other provisions of the Credit Agreement in connection with the Transaction. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+6.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$12.67M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+267.9%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.5%
Latest settlement · 1.0 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 13, 2026
Q3 FY26

TL;DR. Q3 revenue rose 6% and the full-year revenue outlook was raised to $262 to $265 million. Q3 adjusted EBITDA fell to $5.0 million from $5.3 million, and gross margin fell to $8.2 million from $9.4 million.

Bullish
  • + Q3 revenue rose 6% with same-practice revenue growth of 3.2%. new
  • + Full-year 2026 revenue outlook raised to $262 to $265 million. new
  • + Same-practice revenue growth accelerated from the second quarter to 3.2%. new
  • + Hygienist team grew by over 8% in the third quarter. new
  • + Village Family Dental acquisition adds 47 doctors across 12 practices. new
  • + Patient visits increased to 180,955. new
Bearish
  • − Q3 adjusted EBITDA fell to $5.0 million from $5.3 million. new
  • − Q3 gross margin fell to $8.2 million from $9.4 million. new
  • − A $500,000 cybersecurity event impact reduced third-quarter results. new
  • − Nine-month operating cash flow fell $4.8 million to $12.0 million, driven by working capital timing. new
  • − Adjusted gross margin percentage declined 80 basis points. new
  • − Additional second-half costs to onboard and ramp new hygienists. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −5%
below
Price vs 50-day avg −10%
below
RSI (14) 38
neutral
MACD trend Negative
52-week position 63%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −10%
trailing
6-month return −8%
trailing
YTD return +24%
this year
Relative strength −2%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $20 › 200d $19 — 50d above 200d
Institutional flow Accumulating
+4% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.48% of shares out · ▲ +15.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
25 holders — near 1-yr high, broad support
Squeeze score 43
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 73%
annualized · 1-yr
Max drawdown −23%
past year
ATR 8.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 13, 2026
Revenue · full year 2026 $262M – $265M
Adjusted EBITDA · full year 2026 Non-GAAP $21.2M – $22.2M
Previous outlook earlier release · from the 8-K filed Nov 12, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EBITDA margin · Full-Year 2026 8.1% – 8.4%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 5 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−5% Neutral
Price vs 50-day avg
−10% Bearish
RSI (14)
38 Neutral
MACD trend
Negative Bearish
52-week position
63% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $20 › 200d $19 — 50d above 200d
Institutional flow Accumulating
+4% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.48% of shares out · ▲ +15.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
25 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $10 Now $18 · 63% Range high $23
vs 200-day avg -5% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS non-GAAP $10.38M For the nine months ended September 30, 2026 —
affiliated practices 88 As of September 30, 2026 —
capital investments $7.6M first nine months of 2026 —
One third-party payor and their affiliated entities share of condensed consolidated net revenue 25% the three months ended September 30, 2026 filing —
Practicing Affiliated Doctors 225 third quarter of 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PARK
Park Dental Partners, Inc.
this stock
$101.12M +23.8% — — 0.5%
HCA
HCA Healthcare, Inc.
$96.16B -1.4% +7.1% 15.3 2.3%
FSNUY
Fresenius SE & Co. KGaA
$32.17B -0.3% — — 0.0%
THC
Tenet Healthcare Corp
$20.98B +32.6% +0.9% 7.6 2.2%
EHC
Encompass Health Corp
$12.98B +24.6% +10.5% 20.7 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
25
% held
19.7%
Net QoQ
-12.0K sh
Top holder
KENNEDY CAPITAL MANAGEMEN…
Held Float
View
Held by Funds
Fund positions
17
View
Short & Settlement
Short Interest Rising
Shares short
26.6K
Days to cover
1.0d
Change
+3.6K sh
View
Short Volume
Short vol %
62%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$29.7K
As of
Oct 15, 2026
View
Off-Exchange
Off-exchange %
14.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
8-K/A
Filed
Nov 13, 2026
This year
19

Park Dental Partners corrected midpoint growth to 7.8% for revenue and (1.4)% for Adjusted EBITDA; the $262.0 – $265.0 revenue and $21.2 – $22.2 Adjusted EBITDA ranges were unchanged.

View
Exempt Offerings
Offering
$9.2M
Filed
Nov 16, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 13, 2026
View
Investor Relations
Latest news
Park Dental Partners Announces Th…
Published
Nov 13, 2026
View

Performance

5D 20D 120D MTD YTD
PARK -13.8% -9.7% -7.6% -13.4% +23.8%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -8.3% -3.4% -2.0% -8.1% +18.8%
Key facts CIK 2069604 CUSIP 700402100 13F (30d) 26 filings 24 filers Visit website Investor relations